Sema4|GeneDx collaborates on new research demonstrating genome and exome sequencing deliver more diagnostic certainty than multi-gene panels
October 26, 2022 08:00 ET
|
Sema4
STAMFORD, Conn., Oct. 26, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), a health insights company, has collaborated on research debunking a commonly held belief that exome and genome sequencing...
$1.2+ Billion Worldwide Direct-To-Consumer Genetic Testing Industry to 2027 - Rising Public Awareness and Consumer Empowerment Will Support Market Growth
October 20, 2022 08:08 ET
|
Research and Markets
Dublin, Oct. 20, 2022 (GLOBE NEWSWIRE) -- The "Global Direct-To-Consumer Genetic Testing Market By Test Type, By Technology chips, Targeted Analysis, Whole Genome Sequencing, By Sample, By...
Study Demonstrates the Utility of Exome Sequencing for Diagnosing Autism Spectrum Disorders
October 13, 2022 08:00 ET
|
Sema4
Research from 19,000 patients with Autism Spectrum Disorders found approximately 90% had prior negative tests, likely contributing to a longer time to diagnosis Data will be presented at the Child...
US Genetic Testing Market Size to Hit USD 10.29 Billion by 2027
October 07, 2022 07:28 ET
|
Fortune Business Insights
Pune, India, Oct. 07, 2022 (GLOBE NEWSWIRE) -- The US Genetic Testing Market size is expected to achievement momentum by reaching USD 10.29 billion by 2027 while exhibiting an impressive CAGR of...
Global Genetic Testing Market Analysis & Forecasts, 2016-2021 & 2022-2031: Predictive, Carrier, Prenatal and Newborn, Diagnostic, Pharmacogenomic, & Nutrigenomic Testing
October 06, 2022 06:08 ET
|
Research and Markets
Dublin, Oct. 06, 2022 (GLOBE NEWSWIRE) -- The "Genetic Testing Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.The global genetic testing market is expected to...
Family Cancer History Still a Mystery to Many Women, Myriad Genetics Survey Finds
September 28, 2022 09:00 ET
|
Myriad Genetics, Inc.
SALT LAKE CITY, Sept. 28, 2022 (GLOBE NEWSWIRE) -- Myriad Genetics (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced results from a nationwide survey it conducted...
Global Rare Disease Genetic Testing Market Report 2022: Government & Regulatory Support for Rare Disease Diagnosis to Drive Growth
September 16, 2022 04:28 ET
|
Research and Markets
Dublin, Sept. 16, 2022 (GLOBE NEWSWIRE) -- The "Rare Disease Genetic Testing Market Size, Share & Trends Analysis Report by Disease Type (Neurological, CVDs), by Specialty (Molecular,...
Florida Cancer Specialists & Research Institute Celebrates Addition of Next-Generation Genomic Testing Capabilities to Advance Precision Oncology Approach to Patient Care
September 06, 2022 12:26 ET
|
Florida Cancer Specialists & Research Institute
Fort Myers, Fla., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Florida Cancer Specialists & Research Institute, LLC (FCS) celebrated the addition of genomic testing capabilities at its Next Generation...
Novo estudo publicado no Clinical Cancer Research Journal destaca o uso do teste EndoPredict para informar o tratamento em pacientes com câncer de mama na pré-menopausa
August 31, 2022 08:00 ET
|
Myriad Genetics, Inc.
O teste EndoPredict, da Myriad Genetics, identificou com precisão mulheres na pré-menopausa com câncer de mama ER+, HER2- que poderiam evitar, com segurança, a quimioterapia adjuvante SALT LAKE CITY,...
Nuevo estudio publicado en Clinical Cancer Research Journal destaca el uso de la prueba EndoPredict para informar el tratamiento en pacientes premenopáusicas con cáncer de mama
August 31, 2022 08:00 ET
|
Myriad Genetics, Inc.
La prueba EndoPredict de Myriad Genetics identificó con precisión a mujeres premenopáusicas con cáncer de mama ER+, HER2- que podrían evitar la quimioterapia adyuvante de forma segura SALT LAKE CITY,...